메뉴 건너뛰기




Volumn 15, Issue 6, 2018, Pages 382-396

The gut microbiota influences anticancer immunosurveillance and general health

(6)  Routy, Bertrand a,b,c,d   Gopalakrishnan, Vancheswaran e   Daillère, Romain a,b,c   Zitvogel, Laurence a,b,c,f   Wargo, Jennifer A e   Kroemer, Guido g,h,i,j,k,l,m  


Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB; METFORMIN; PEMBROLIZUMAB; PHENFORMIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; CD274 PROTEIN, HUMAN; PDCD1 PROTEIN, HUMAN;

EID: 85045141286     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/s41571-018-0006-2     Document Type: Review
Times cited : (389)

References (166)
  • 1
    • 0036852241 scopus 로고    scopus 로고
    • Cancer immunoediting: From immunosurveillance to tumor escape
    • Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998 (2002).
    • (2002) Nat. Immunol. , vol.3 , pp. 991-998
    • Dunn, G.P.1    Bruce, A.T.2    Ikeda, H.3    Old, L.J.4    Schreiber, R.D.5
  • 2
    • 4143141823 scopus 로고    scopus 로고
    • The immunobiology of cancer immunosurveillance and immunoediting
    • Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (2004).
    • (2004) Immunity , vol.21 , pp. 137-148
    • Dunn, G.P.1    Old, L.J.2    Schreiber, R.D.3
  • 3
    • 84874872137 scopus 로고    scopus 로고
    • BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
    • Frederick, D. T. et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin. Cancer Res. 19, 1225-1231 (2013).
    • (2013) Clin. Cancer Res. , vol.19 , pp. 1225-1231
    • Frederick, D.T.1
  • 4
    • 84956607773 scopus 로고    scopus 로고
    • Immunological effects of conventional chemotherapy and targeted anticancer agents
    • Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690-714 (2015).
    • (2015) Cancer Cell , vol.28 , pp. 690-714
    • Galluzzi, L.1    Buque, A.2    Kepp, O.3    Zitvogel, L.4    Kroemer, G.5
  • 7
    • 85019916892 scopus 로고    scopus 로고
    • Interaction of molecular alterations with immune response in melanoma
    • Szczepaniak Sloane, R. A. et al. Interaction of molecular alterations with immune response in melanoma. Cancer 123, 2130-2142 (2017).
    • (2017) Cancer , vol.123 , pp. 2130-2142
    • Szczepaniak Sloane, R.A.1
  • 8
    • 84928774156 scopus 로고    scopus 로고
    • The future of immune checkpoint therapy
    • Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56-61 (2015).
    • (2015) Science , vol.348 , pp. 56-61
    • Sharma, P.1    Allison, J.P.2
  • 9
    • 84927130807 scopus 로고    scopus 로고
    • Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential
    • Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential. Cell 161, 205-214 (2015).
    • (2015) Cell , vol.161 , pp. 205-214
    • Sharma, P.1    Allison, J.P.2
  • 10
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010).
    • (2010) N. Engl. J. Med. , vol.363 , pp. 711-723
    • Hodi, F.S.1
  • 11
    • 84938205998 scopus 로고    scopus 로고
    • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial
    • Ribas, A. et al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial. Lancet Oncol. 16, 908-918 (2015).
    • (2015) Lancet Oncol. , vol.16 , pp. 908-918
    • Ribas, A.1
  • 12
    • 84859393995 scopus 로고    scopus 로고
    • CTLA-4 blockade with ipilimumab: Long-Term follow-up of 177 patients with metastatic melanoma
    • Prieto, P. A. et al. CTLA-4 blockade with ipilimumab: long-Term follow-up of 177 patients with metastatic melanoma. Clin. Cancer Res. 18, 2039-2047 (2012).
    • (2012) Clin. Cancer Res. , vol.18 , pp. 2039-2047
    • Prieto, P.A.1
  • 13
    • 0029120245 scopus 로고
    • CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
    • Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465 (1995).
    • (1995) J. Exp. Med. , vol.182 , pp. 459-465
    • Krummel, M.F.1    Allison, J.P.2
  • 14
    • 0029947568 scopus 로고    scopus 로고
    • Enhancement of antitumor immunity by CTLA-4 blockade
    • Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736 (1996).
    • (1996) Science , vol.271 , pp. 1734-1736
    • Leach, D.R.1    Krummel, M.F.2    Allison, J.P.3
  • 15
    • 84899748384 scopus 로고    scopus 로고
    • + tumor-reactive repertoire infiltrating human tumors
    • + tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246-2259 (2014).
    • (2014) J. Clin. Invest. , vol.124 , pp. 2246-2259
    • Gros, A.1
  • 16
    • 84862859820 scopus 로고    scopus 로고
    • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
    • Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443-2454 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , pp. 2443-2454
    • Topalian, S.L.1
  • 17
    • 84862903106 scopus 로고    scopus 로고
    • Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
    • Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455-2465 (2012).
    • (2012) N. Engl. J. Med. , vol.366 , pp. 2455-2465
    • Brahmer, J.R.1
  • 18
    • 84929481481 scopus 로고    scopus 로고
    • Pembrolizumab versus ipilimumab in advanced melanoma
    • Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372, 2521-2532 (2015).
    • (2015) N. Engl. J. Med. , vol.372 , pp. 2521-2532
    • Robert, C.1
  • 19
    • 84879759020 scopus 로고    scopus 로고
    • Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma
    • Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369, 134-144 (2013).
    • (2013) N. Engl. J. Med. , vol.369 , pp. 134-144
    • Hamid, O.1
  • 20
    • 84942089321 scopus 로고    scopus 로고
    • Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
    • Larkin, J., Hodi, F. S. & Wolchok, J. D. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 1270-1271 (2015).
    • (2015) N. Engl. J. Med. , vol.373 , pp. 1270-1271
    • Larkin, J.1    Hodi, F.S.2    Wolchok, J.D.3
  • 21
    • 84929481482 scopus 로고    scopus 로고
    • Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
    • Postow, M. A. et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006-2017 (2015).
    • (2015) N. Engl. J. Med. , vol.372 , pp. 2006-2017
    • Postow, M.A.1
  • 22
    • 85033576428 scopus 로고    scopus 로고
    • Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
    • Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91-97 (2018).
    • (2018) Science , vol.359 , pp. 91-97
    • Routy, B.1
  • 23
    • 85019706772 scopus 로고    scopus 로고
    • Antibiotic use does not appear to influence response to nivolumab
    • Kaderbhai, C. et al. Antibiotic use does not appear to influence response to nivolumab. Anticancer Res. 37, 3195-3200 (2017).
    • (2017) Anticancer Res. , vol.37 , pp. 3195-3200
    • Kaderbhai, C.1
  • 24
    • 85016548232 scopus 로고    scopus 로고
    • Elements of cancer immunity and the cancer-immune set point
    • Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321-330 (2017).
    • (2017) Nature , vol.541 , pp. 321-330
    • Chen, D.S.1    Mellman, I.2
  • 25
    • 84888059687 scopus 로고    scopus 로고
    • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
    • Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976 (2013).
    • (2013) Science , vol.342 , pp. 971-976
    • Viaud, S.1
  • 26
    • 84888049920 scopus 로고    scopus 로고
    • Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment
    • Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970 (2013).
    • (2013) Science , vol.342 , pp. 967-970
    • Iida, N.1
  • 27
    • 84994831796 scopus 로고    scopus 로고
    • Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects
    • Daillere, R. et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45, 931-943 (2016).
    • (2016) Immunity , vol.45 , pp. 931-943
    • Daillere, R.1
  • 28
    • 85021854564 scopus 로고    scopus 로고
    • Intestinal microbiota and relapse after hematopoietic-cell transplantation
    • Peled, J. U. et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J. Clin. Oncol. 35, 1650-1659 (2017).
    • (2017) J. Clin. Oncol. , vol.35 , pp. 1650-1659
    • Peled, J.U.1
  • 29
    • 84948461699 scopus 로고    scopus 로고
    • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
    • Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084 (2015).
    • (2015) Science , vol.350 , pp. 1079-1084
    • Vetizou, M.1
  • 30
    • 84948451779 scopus 로고    scopus 로고
    • Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
    • Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089 (2015).
    • (2015) Science , vol.350 , pp. 1084-1089
    • Sivan, A.1
  • 31
    • 85018374876 scopus 로고    scopus 로고
    • The role of the microbiome in cancer development and therapy
    • Bhatt, A. P., Redinbo, M. R. & Bultman, S. J. The role of the microbiome in cancer development and therapy. CA Cancer J. Clin. 67, 326-344 (2017).
    • (2017) CA Cancer J. Clin. , vol.67 , pp. 326-344
    • Bhatt, A.P.1    Redinbo, M.R.2    Bultman, S.J.3
  • 32
    • 84875246466 scopus 로고    scopus 로고
    • Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing
    • Berry, D. et al. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl Acad. Sci. USA 110, 4720-4725 (2013).
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 4720-4725
    • Berry, D.1
  • 33
    • 5444248493 scopus 로고    scopus 로고
    • Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
    • Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469-1476 (2004).
    • (2004) Int. J. Syst. Evol. Microbiol. , vol.54 , pp. 1469-1476
    • Derrien, M.1    Vaughan, E.E.2    Plugge, C.M.3    De Vos, W.M.4
  • 34
    • 85028604962 scopus 로고    scopus 로고
    • Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle
    • Ottman, N. et al. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol. 83, e01014-17 (2017).
    • (2017) Appl. Environ. Microbiol. , vol.83 , pp. e01014-e01017
    • Ottman, N.1
  • 35
    • 84996844186 scopus 로고    scopus 로고
    • Adaptation of Akkermansia muciniphila to the oxic-Anoxic interface of the mucus layer
    • Ouwerkerk, J. P. et al. Adaptation of Akkermansia muciniphila to the oxic-Anoxic interface of the mucus layer. Appl. Environ. Microbiol. 82, 6983-6993 (2016).
    • (2016) Appl. Environ. Microbiol. , vol.82 , pp. 6983-6993
    • Ouwerkerk, J.P.1
  • 36
    • 38449104720 scopus 로고    scopus 로고
    • Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly
    • Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767-7770 (2007).
    • (2007) Appl. Environ. Microbiol. , vol.73 , pp. 7767-7770
    • Collado, M.C.1    Derrien, M.2    Isolauri, E.3    De Vos, W.M.4    Salminen, S.5
  • 37
    • 79952294582 scopus 로고    scopus 로고
    • The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes
    • van Passel, M. W. J. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLOS ONE 6, e16876 (2011).
    • (2011) PLoS ONE , vol.6
    • Van Passel, M.W.J.1
  • 38
    • 84959083589 scopus 로고    scopus 로고
    • Akkermansia muciniphila and its role in regulating host functions
    • Derrien, M., Belzer, C. & de Vos, W. M. Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 106, 171-181 (2017).
    • (2017) Microb. Pathog. , vol.106 , pp. 171-181
    • Derrien, M.1    Belzer, C.2    De Vos, W.M.3
  • 39
    • 84883110880 scopus 로고    scopus 로고
    • Richness of human gut microbiome correlates with metabolic markers
    • Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
    • (2013) Nature , vol.500 , pp. 541-546
    • Le Chatelier, E.1
  • 40
    • 84960253261 scopus 로고    scopus 로고
    • Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology
    • Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426-436 (2016).
    • (2016) Gut , vol.65 , pp. 426-436
    • Dao, M.C.1
  • 41
    • 85027927719 scopus 로고    scopus 로고
    • Enterotypes of the human gut microbiome
    • Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
    • (2011) Nature , vol.473 , pp. 174-180
    • Arumugam, M.1
  • 42
    • 85040119520 scopus 로고    scopus 로고
    • The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    • Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104-108 (2018).
    • (2018) Science , vol.359 , pp. 104-108
    • Matson, V.1
  • 43
    • 84947648620 scopus 로고    scopus 로고
    • Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress
    • Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57-71 (2015).
    • (2015) Cancer Cell , vol.27 , pp. 57-71
    • Schug, Z.T.1
  • 44
    • 0024393912 scopus 로고
    • Dissolution and stability of carmustine in the absence of ethanol
    • Levin, V. A. & Levin, E. M. Dissolution and stability of carmustine in the absence of ethanol. Sel. Cancer Ther. 5, 33-35 (1989).
    • (1989) Sel. Cancer Ther. , vol.5 , pp. 33-35
    • Levin, V.A.1    Levin, E.M.2
  • 45
    • 84907223092 scopus 로고    scopus 로고
    • Functional polarization of tumour-Associated macrophages by tumour-derived lactic acid
    • Colegio, O. R. et al. Functional polarization of tumour-Associated macrophages by tumour-derived lactic acid. Nature 513, 559-563 (2014).
    • (2014) Nature , vol.513 , pp. 559-563
    • Colegio, O.R.1
  • 46
    • 84994592466 scopus 로고    scopus 로고
    • LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK cells
    • Brand, A. et al. LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657-671 (2016).
    • (2016) Cell Metab. , vol.24 , pp. 657-671
    • Brand, A.1
  • 47
    • 85020416121 scopus 로고    scopus 로고
    • Microbe profile: Akkermansia muciniphila: A conserved intestinal symbiont that acts as the gatekeeper of our mucosa
    • de Vos, W. M. Microbe profile: Akkermansia muciniphila: A conserved intestinal symbiont that acts as the gatekeeper of our mucosa. Microbiology 163, 646-648 (2017).
    • (2017) Microbiology , vol.163 , pp. 646-648
    • De Vos, W.M.1
  • 48
    • 84878465280 scopus 로고    scopus 로고
    • Cross-Talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
    • Everard, A. et al. Cross-Talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066-9071 (2013).
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 9066-9071
    • Everard, A.1
  • 49
    • 84997701899 scopus 로고    scopus 로고
    • A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
    • Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107-113 (2016).
    • (2016) Nat. Med. , vol.23 , pp. 107-113
    • Plovier, H.1
  • 50
    • 84907021154 scopus 로고    scopus 로고
    • Effect of metformin on metabolic improvement and gut microbiota
    • Lee, H. & Ko, G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80, 5935-5943 (2014).
    • (2014) Appl. Environ. Microbiol. , vol.80 , pp. 5935-5943
    • Lee, H.1    Ko, G.2
  • 51
    • 84949772416 scopus 로고    scopus 로고
    • Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
    • Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015).
    • (2015) Nature , vol.528 , pp. 262-266
    • Forslund, K.1
  • 52
    • 85031767787 scopus 로고    scopus 로고
    • Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway
    • Bauer, P. V. et al. Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway. Cell Metab. 27, 101-117 (2018).
    • (2018) Cell Metab. , vol.27 , pp. 101-117
    • Bauer, P.V.1
  • 53
    • 85027587777 scopus 로고    scopus 로고
    • Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-Analysis
    • Campbell, J. M., Bellman, S. M., Stephenson, M. D. & Lisy, K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-Analysis. Ageing Res. Rev. 40, 31-44 (2017).
    • (2017) Ageing Res. Rev. , vol.40 , pp. 31-44
    • Campbell, J.M.1    Bellman, S.M.2    Stephenson, M.D.3    Lisy, K.4
  • 54
    • 84883813272 scopus 로고    scopus 로고
    • Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella typhimurium-infected gnotobiotic mice
    • Ganesh, B. P., Klopfleisch, R., Loh, G. & Blaut, M. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella typhimurium-infected gnotobiotic mice. PLoS ONE 8, e74963 (2013).
    • (2013) PLoS ONE , vol.8
    • Ganesh, B.P.1    Klopfleisch, R.2    Loh, G.3    Blaut, M.4
  • 55
    • 84902262539 scopus 로고    scopus 로고
    • Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice
    • Hakansson, A. et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin. Exp. Med. 15, 107-120 (2015).
    • (2015) Clin. Exp. Med. , vol.15 , pp. 107-120
    • Hakansson, A.1
  • 56
    • 84886286566 scopus 로고    scopus 로고
    • Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis
    • Kang, C. S. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8, e76520 (2013).
    • (2013) PLoS ONE , vol.8
    • Kang, C.S.1
  • 57
    • 84891585929 scopus 로고    scopus 로고
    • The gut microbiome modulates colon tumorigenesis
    • Zackular, J. P. et al. The gut microbiome modulates colon tumorigenesis. mBio 4, e00692-13 (2013).
    • (2013) MBio , vol.4 , pp. e00692-e00713
    • Zackular, J.P.1
  • 58
    • 84984551811 scopus 로고    scopus 로고
    • Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice
    • Dingemanse, C. et al. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis 36, 1388-1396 (2015).
    • (2015) Carcinogenesis , vol.36 , pp. 1388-1396
    • Dingemanse, C.1
  • 59
    • 85014547105 scopus 로고    scopus 로고
    • NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury
    • Seregin, S. S. et al. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol. 10, 434-445 (2017).
    • (2017) Mucosal Immunol. , vol.10 , pp. 434-445
    • Seregin, S.S.1
  • 60
    • 79953890383 scopus 로고    scopus 로고
    • Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis
    • Zella, G. C. et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel Dis. 17, 1092-1100 (2011).
    • (2011) Inflamm. Bowel Dis. , vol.17 , pp. 1092-1100
    • Zella, G.C.1
  • 61
    • 84969591057 scopus 로고    scopus 로고
    • Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
    • Shono, Y. et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl Med. 8, 339ra71 (2016).
    • (2016) Sci. Transl Med. , vol.8 , pp. 339ra71
    • Shono, Y.1
  • 63
    • 0037478707 scopus 로고    scopus 로고
    • Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces
    • Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M. & Flint, H. J. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320-4324 (2003).
    • (2003) Appl. Environ. Microbiol. , vol.69 , pp. 4320-4324
    • Hold, G.L.1    Schwiertz, A.2    Aminov, R.I.3    Blaut, M.4    Flint, H.J.5
  • 64
    • 85021740602 scopus 로고    scopus 로고
    • Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. Prausnitzii as a next-generation probiotic
    • Martín, R. et al. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a next-generation probiotic. Front. Microbiol. 8, 1226 (2017).
    • (2017) Front. Microbiol. , vol.8 , pp. 1226
    • Martín, R.1
  • 65
    • 20444393973 scopus 로고    scopus 로고
    • Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota
    • Lay, C. et al. Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ. Microbiol. 7, 933-946 (2005).
    • (2005) Environ. Microbiol. , vol.7 , pp. 933-946
    • Lay, C.1
  • 66
    • 0036866628 scopus 로고    scopus 로고
    • Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov
    • Duncan, S. H., Hold, G. L., Harmsen, H. J., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141-2146 (2002).
    • (2002) Int. J. Syst. Evol. Microbiol. , vol.52 , pp. 2141-2146
    • Duncan, S.H.1    Hold, G.L.2    Harmsen, H.J.3    Stewart, C.S.4    Flint, H.J.5
  • 67
    • 0028126050 scopus 로고
    • Effects of short chain fatty acids on gut morphology and function
    • Scheppach, W. Effects of short chain fatty acids on gut morphology and function. Gut 35, S35-S38 (1994).
    • (1994) Gut , vol.35 , pp. S35-S38
    • Scheppach, W.1
  • 68
    • 84877913270 scopus 로고    scopus 로고
    • Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
    • Wrzosek, L. et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11, 61 (2013).
    • (2013) BMC Biol. , vol.11
    • Wrzosek, L.1
  • 69
    • 70349488325 scopus 로고    scopus 로고
    • Low counts of Faecalibacterium prausnitzii in colitis microbiota
    • Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183-1189 (2009).
    • (2009) Inflamm. Bowel Dis. , vol.15 , pp. 1183-1189
    • Sokol, H.1
  • 70
    • 55949124035 scopus 로고    scopus 로고
    • Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
    • Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731-16736 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , pp. 16731-16736
    • Sokol, H.1
  • 71
    • 80054857288 scopus 로고    scopus 로고
    • Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome
    • Rajilic-Stojanovic, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801 (2011).
    • (2011) Gastroenterology , vol.141 , pp. 1792-1801
    • Rajilic-Stojanovic, M.1
  • 72
    • 41849127118 scopus 로고    scopus 로고
    • Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
    • Turnbaugh, P. J., Baeckhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008).
    • (2008) Cell Host Microbe , vol.3 , pp. 213-223
    • Turnbaugh, P.J.1    Baeckhed, F.2    Fulton, L.3    Gordon, J.I.4
  • 73
    • 84888133800 scopus 로고    scopus 로고
    • Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2diabetes: Correlation with inflammatory and metabolic parameters
    • Graessler, J. et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenom. J. 13, 514-522 (2013).
    • (2013) Pharmacogenom. J. , vol.13 , pp. 514-522
    • Graessler, J.1
  • 74
    • 77449095695 scopus 로고    scopus 로고
    • Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children
    • Balamurugan, R. et al. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 103, 335-338 (2010).
    • (2010) Br. J. Nutr. , vol.103 , pp. 335-338
    • Balamurugan, R.1
  • 75
    • 84883181684 scopus 로고    scopus 로고
    • Human gut microbiota changes reveal the progression of glucose intolerance
    • Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLOS ONE 8, e71108 (2013).
    • (2013) PLOS ONE , vol.8
    • Zhang, X.1
  • 76
    • 84878709716 scopus 로고    scopus 로고
    • Gut metagenome in European women with normal, impaired and diabetic glucose control
    • Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
    • (2013) Nature , vol.498 , pp. 99-103
    • Karlsson, F.H.1
  • 77
    • 77949886724 scopus 로고    scopus 로고
    • Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children
    • De Palma, G. et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10, 63 (2010).
    • (2010) BMC Microbiol. , vol.10 , pp. 63
    • De Palma, G.1
  • 78
    • 73749087464 scopus 로고    scopus 로고
    • Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects
    • De Palma, G., Nadal, I., Collado, M. C. & Sanz, Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br. J. Nutr. 102, 1154-1160 (2009).
    • (2009) Br. J. Nutr. , vol.102 , pp. 1154-1160
    • De Palma, G.1    Nadal, I.2    Collado, M.C.3    Sanz, Y.4
  • 79
    • 77955602581 scopus 로고    scopus 로고
    • Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians
    • Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLOS ONE 5, e10667 (2010).
    • (2010) PLOS ONE , vol.5
    • Biagi, E.1
  • 80
    • 84908043065 scopus 로고    scopus 로고
    • Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
    • Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl Acad. Sci. USA 111, E4485-E4493 (2014).
    • (2014) Proc. Natl Acad. Sci. USA , vol.111 , pp. E4485-E4493
    • Leclercq, S.1
  • 82
    • 85033587326 scopus 로고    scopus 로고
    • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
    • Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97-103 (2018).
    • (2018) Science , vol.359 , pp. 97-103
    • Gopalakrishnan, V.1
  • 83
    • 85031736103 scopus 로고    scopus 로고
    • Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients
    • Frankel, A. E. et al. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia 19, 848-855 (2017).
    • (2017) Neoplasia , vol.19 , pp. 848-855
    • Frankel, A.E.1
  • 84
    • 85021170776 scopus 로고    scopus 로고
    • Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
    • Chaput, N. et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann. Oncol. 28, 1368-1379 (2017).
    • (2017) Ann. Oncol. , vol.28 , pp. 1368-1379
    • Chaput, N.1
  • 85
    • 85029177365 scopus 로고    scopus 로고
    • Bifidobacteria and their health-promoting effects
    • Hidalgo-Cantabrana, C. et al. Bifidobacteria and their health-promoting effects. Microbiol. Spectr. https://doi.org/10.1128/microbiolspec.BAD-0010-2016 (2018).
    • Microbiol. Spectr
    • Hidalgo-Cantabrana, C.1
  • 87
    • 25444502912 scopus 로고    scopus 로고
    • Review article: Bifidobacteria as probiotic agents-physiological effects and clinical benefits
    • Picard, C. et al. Review article: Bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22, 495-512 (2005).
    • (2005) Aliment. Pharmacol. Ther. , vol.22 , pp. 495-512
    • Picard, C.1
  • 89
    • 34250869582 scopus 로고    scopus 로고
    • Description of a new species. Bifidobacterium crudilactis sp. nov., isolated from raw milk and raw milk cheeses
    • Delcenserie, V. et al. Description of a new species. Bifidobacterium crudilactis sp. nov., isolated from raw milk and raw milk cheeses. Syst. Appl. Microbiol. 30, 381-389 (2007).
    • (2007) Syst. Appl. Microbiol. , vol.30 , pp. 381-389
    • Delcenserie, V.1
  • 90
    • 27744555553 scopus 로고    scopus 로고
    • Comparison between Gram stain and culture for the characterization of vaginal microflora: Definition of a distinct grade that resembles grade i microflora and revised categorization of grade i microflora
    • Verhelst, R. et al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 5, 61 (2005).
    • (2005) BMC Microbiol. , vol.5 , pp. 61
    • Verhelst, R.1
  • 92
    • 84868539335 scopus 로고    scopus 로고
    • Facultative to strict anaerobes ratio in the preterm infant microbiota: A target for intervention?
    • Arboleya, S., Solis, G., Fernandez, N., de los Reyes-Gavilan, C. G. & Gueimonde, M. Facultative to strict anaerobes ratio in the preterm infant microbiota: A target for intervention? Gut Microbes 3, 583-588 (2012).
    • (2012) Gut Microbes , vol.3 , pp. 583-588
    • Arboleya, S.1    Solis, G.2    Fernandez, N.3    De Los Reyes-Gavilan, C.G.4    Gueimonde, M.5
  • 93
    • 0037195083 scopus 로고    scopus 로고
    • The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract
    • Schell, M. A. et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl Acad. Sci. USA 99, 14422-14427 (2002).
    • (2002) Proc. Natl Acad. Sci. USA , vol.99 , pp. 14422-14427
    • Schell, M.A.1
  • 94
    • 84907267761 scopus 로고    scopus 로고
    • Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics
    • Lugli, G. A. et al. Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics. Appl. Environ. Microbiol. 80, 6383-6394 (2014).
    • (2014) Appl. Environ. Microbiol. , vol.80 , pp. 6383-6394
    • Lugli, G.A.1
  • 95
    • 84907266451 scopus 로고    scopus 로고
    • Genomic encyclopedia of type strains of the genus Bifidobacterium
    • Milani, C. et al. Genomic encyclopedia of type strains of the genus Bifidobacterium. Appl. Environ. Microbiol. 80, 6290-6302 (2014).
    • (2014) Appl. Environ. Microbiol. , vol.80 , pp. 6290-6302
    • Milani, C.1
  • 96
    • 84905560481 scopus 로고    scopus 로고
    • The microbiota of human milk in healthy women
    • Fernandez, L. et al. The microbiota of human milk in healthy women. Cell. Mol. Biol. 59, 31-42 (2013).
    • (2013) Cell. Mol. Biol. , vol.59 , pp. 31-42
    • Fernandez, L.1
  • 97
    • 59949097833 scopus 로고    scopus 로고
    • Isolation of Bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-Time PCR
    • Martín, R. et al. Isolation of Bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-Time PCR. Appl. Environ. Microbiol. 75, 965-969 (2009).
    • (2009) Appl. Environ. Microbiol. , vol.75 , pp. 965-969
    • Martín, R.1
  • 98
    • 33845508443 scopus 로고    scopus 로고
    • Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host
    • Sonnenburg, J. L., Chen, C. T. & Gordon, J. I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4, e413 (2006).
    • (2006) PLoS Biol. , vol.4
    • Sonnenburg, J.L.1    Chen, C.T.2    Gordon, J.I.3
  • 99
    • 84938931406 scopus 로고    scopus 로고
    • Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria
    • Rios-Covian, D. et al. Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria. Front. Microbiol. 6, 825 (2015).
    • (2015) Front. Microbiol. , vol.6 , pp. 825
    • Rios-Covian, D.1
  • 100
    • 84957930912 scopus 로고    scopus 로고
    • Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis
    • Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J. & de los Reyes-Gavilan, C. G. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 362, fnv176 (2015).
    • (2015) FEMS Microbiol. Lett. , vol.362 , pp. fnv176
    • Rios-Covian, D.1    Gueimonde, M.2    Duncan, S.H.3    Flint, H.J.4    De Los Reyes-Gavilan, C.G.5
  • 101
    • 84945942210 scopus 로고    scopus 로고
    • Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut
    • Milani, C. et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci. Rep. 5, 15782 (2015).
    • (2015) Sci. Rep. , vol.5
    • Milani, C.1
  • 102
    • 84926468863 scopus 로고    scopus 로고
    • Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium
    • Egan, M. et al. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 14, 282 (2014).
    • (2014) BMC Microbiol. , vol.14 , pp. 282
    • Egan, M.1
  • 103
    • 84855444412 scopus 로고    scopus 로고
    • reg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy
    • reg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy. Vaccine 30, 825-829 (2012).
    • (2012) Vaccine , vol.30 , pp. 825-829
    • Lopez, P.1
  • 104
    • 2942717102 scopus 로고    scopus 로고
    • In vivo effects of Bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in BALB/C mice
    • Griffiths, E. A. et al. In vivo effects of Bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in BALB/C mice. Dig. Dis. Sci. 49, 579-589 (2004).
    • (2004) Dig. Dis. Sci. , vol.49 , pp. 579-589
    • Griffiths, E.A.1
  • 105
    • 0037776007 scopus 로고    scopus 로고
    • The relationship between intestinal Bifidobacteria and bacteria/endotoxin translocation in scalded rats [Chinese]
    • Wang, Z. et al. The relationship between intestinal Bifidobacteria and bacteria/endotoxin translocation in scalded rats [Chinese]. Zhonghua Shao Shang Za Zhi 18, 365-368 (2002).
    • (2002) Zhonghua Shao Shang Za Zhi , vol.18 , pp. 365-368
    • Wang, Z.1
  • 106
    • 33748752611 scopus 로고    scopus 로고
    • The role of Bifidobacteria in gut barrier function after thermal injury in rats
    • Wang, Z. et al. The role of Bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma 61, 650-657 (2006).
    • (2006) J. Trauma , vol.61 , pp. 650-657
    • Wang, Z.1
  • 107
    • 12344249654 scopus 로고    scopus 로고
    • Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial
    • Furrie, E. et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 54, 242-249 (2005).
    • (2005) Gut , vol.54 , pp. 242-249
    • Furrie, E.1
  • 108
    • 84991509161 scopus 로고    scopus 로고
    • Probiotics-to use, or not to use? An updated meta-Analysis
    • Billimoria, Z. C., Pandya, S., Bhatt, P. & Pandya, B. Probiotics-to use, or not to use? An updated meta-Analysis. Clin. Pediatr. 55, 1242-1244 (2016).
    • (2016) Clin. Pediatr. , vol.55 , pp. 1242-1244
    • Billimoria, Z.C.1    Pandya, S.2    Bhatt, P.3    Pandya, B.4
  • 109
    • 84957845119 scopus 로고    scopus 로고
    • Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial
    • Costeloe, K., Hardy, P., Juszczak, E., Wilks, M. & Millar, M. R. Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial. Lancet 387, 649-660 (2016).
    • (2016) Lancet , vol.387 , pp. 649-660
    • Costeloe, K.1    Hardy, P.2    Juszczak, E.3    Wilks, M.4    Millar, M.R.5
  • 110
    • 77954838946 scopus 로고    scopus 로고
    • Effects of four Bifidobacteria on obesity in high-fat diet induced rats
    • Yin, Y. N., Yu, Q. F., Fu, N., Liu, X. W. & Lu, F. G. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16, 3394-3401 (2010).
    • (2010) World J. Gastroenterol. , vol.16 , pp. 3394-3401
    • Yin, Y.N.1    Yu, Q.F.2    Fu, N.3    Liu, X.W.4    Lu, F.G.5
  • 111
    • 85078391854 scopus 로고    scopus 로고
    • Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 6: Suitability of taxonomic units notified to EFSA until March 2017
    • [No authors listed.] Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017. EFSA J. 15, 4884 (2017).
    • (2017) EFSA J. , vol.15 , pp. 4884
  • 113
    • 84878143512 scopus 로고    scopus 로고
    • Probiotic VSL#3 prevents antibiotic-Associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial
    • Selinger, C. P. et al. Probiotic VSL#3 prevents antibiotic-Associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J. Hosp. Infect. 84, 159-165 (2013).
    • (2013) J. Hosp. Infect. , vol.84 , pp. 159-165
    • Selinger, C.P.1
  • 114
    • 84977564759 scopus 로고    scopus 로고
    • Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway
    • Yu, J. et al. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int. J. Cancer 139, 1318-1326 (2016).
    • (2016) Int. J. Cancer , vol.139 , pp. 1318-1326
    • Yu, J.1
  • 115
    • 84928621098 scopus 로고    scopus 로고
    • Intracellular colon cancer-Associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression
    • Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A. & Bringer, M. A. Intracellular colon cancer-Associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab. Invest. 95, 296-307 (2015).
    • (2015) Lab. Invest. , vol.95 , pp. 296-307
    • Raisch, J.1    Rolhion, N.2    Dubois, A.3    Darfeuille-Michaud, A.4    Bringer, M.A.5
  • 116
    • 84993820006 scopus 로고    scopus 로고
    • Microbial dysbiosis and colon carcinogenesis: Could colon cancer be considered a bacteria-related disease?
    • Sobhani, I. et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther. Adv. Gastroenterol. 6, 215-229 (2013).
    • (2013) Ther. Adv. Gastroenterol. , vol.6 , pp. 215-229
    • Sobhani, I.1
  • 117
    • 84878699293 scopus 로고    scopus 로고
    • The role of gut microbiota in the pathogenesis of colorectal cancer
    • Zhu, Q., Gao, R., Wu, W. & Qin, H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biol. 34, 1285-1300 (2013).
    • (2013) Tumor Biol. , vol.34 , pp. 1285-1300
    • Zhu, Q.1    Gao, R.2    Wu, W.3    Qin, H.4
  • 118
    • 84879506452 scopus 로고    scopus 로고
    • Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer
    • Ohigashi, S. et al. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig. Dis. Sci. 58, 1717-1726 (2013).
    • (2013) Dig. Dis. Sci. , vol.58 , pp. 1717-1726
    • Ohigashi, S.1
  • 119
    • 77649211541 scopus 로고    scopus 로고
    • Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats
    • Le Leu, R. K., Hu, Y., Brown, I. L., Woodman, R. J. & Young, G. P. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31, 246-251 (2010).
    • (2010) Carcinogenesis , vol.31 , pp. 246-251
    • Le Leu, R.K.1    Hu, Y.2    Brown, I.L.3    Woodman, R.J.4    Young, G.P.5
  • 120
    • 33947542115 scopus 로고    scopus 로고
    • Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients
    • Roller, M., Clune, Y., Collins, K., Rechkemmer, G. & Watzl, B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 97, 676-684 (2007).
    • (2007) Br. J. Nutr. , vol.97 , pp. 676-684
    • Roller, M.1    Clune, Y.2    Collins, K.3    Rechkemmer, G.4    Watzl, B.5
  • 121
    • 70349570169 scopus 로고    scopus 로고
    • A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: Effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer
    • Worthley, D. L. et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am. J. Clin. Nutr. 90, 578-586 (2009).
    • (2009) Am. J. Clin. Nutr. , vol.90 , pp. 578-586
    • Worthley, D.L.1
  • 122
    • 33846878508 scopus 로고    scopus 로고
    • Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients
    • Rafter, J. et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85, 488-496 (2007).
    • (2007) Am. J. Clin. Nutr. , vol.85 , pp. 488-496
    • Rafter, J.1
  • 123
    • 84925438265 scopus 로고    scopus 로고
    • Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: A double-center and double-blind randomized clinical trial
    • Liu, Z. et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: A double-center and double-blind randomized clinical trial. BMC Gastroenterol. 15, 34 (2015).
    • (2015) BMC Gastroenterol. , vol.15 , pp. 34
    • Liu, Z.1
  • 124
    • 84871951482 scopus 로고    scopus 로고
    • The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: A double-center and double-blind randomized clinical trial
    • Liu, Z.-H. et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: A double-center and double-blind randomized clinical trial. Am. J. Clin. Nutr. 97, 117-126 (2013).
    • (2013) Am. J. Clin. Nutr , vol.97 , pp. 117-126
    • Liu, Z.-H.1
  • 125
    • 77953610750 scopus 로고    scopus 로고
    • Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
    • Wada, M. et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support. Care Cancer 18, 751-759 (2010).
    • (2010) Support. Care Cancer , vol.18 , pp. 751-759
    • Wada, M.1
  • 126
    • 33750550865 scopus 로고    scopus 로고
    • Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial
    • Xiao, J. Z. et al. Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin. Exp. Allergy 36, 1425-1435 (2006).
    • (2006) Clin. Exp. Allergy , vol.36 , pp. 1425-1435
    • Xiao, J.Z.1
  • 127
    • 34848832109 scopus 로고    scopus 로고
    • Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled study
    • Malaguarnera, M. et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled study. Dig. Dis. Sci. 52, 3259-3265 (2007).
    • (2007) Dig. Dis. Sci. , vol.52 , pp. 3259-3265
    • Malaguarnera, M.1
  • 128
    • 77955399038 scopus 로고    scopus 로고
    • Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly
    • Namba, K., Hatano, M., Yaeshima, T., Takase, M. & Suzuki, K. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci. Biotechnol. Biochem. 74, 939-945 (2010).
    • (2010) Biosci. Biotechnol. Biochem. , vol.74 , pp. 939-945
    • Namba, K.1    Hatano, M.2    Yaeshima, T.3    Takase, M.4    Suzuki, K.5
  • 129
    • 84956743698 scopus 로고    scopus 로고
    • Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial
    • Tamaki, H. et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig. Endosc. 28, 67-74 (2016).
    • (2016) Dig. Endosc. , vol.28 , pp. 67-74
    • Tamaki, H.1
  • 130
    • 85023596392 scopus 로고    scopus 로고
    • + T cell response and better prognosis in HBV-related hepatocellular carcinoma
    • + T cell response and better prognosis in HBV-related hepatocellular carcinoma. Exp. Cell Res. 358, 352-359 (2017).
    • (2017) Exp. Cell Res. , vol.358 , pp. 352-359
    • Rong, Y.1
  • 131
    • 0037328974 scopus 로고    scopus 로고
    • Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth
    • Li, X. et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther. 10, 105 (2003).
    • (2003) Cancer Gene Ther. , vol.10 , pp. 105
    • Li, X.1
  • 132
    • 6944225464 scopus 로고    scopus 로고
    • Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation
    • Kuwahara, T. et al. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Natl Acad. Sci. USA 101, 14919-14924 (2004).
    • (2004) Proc. Natl Acad. Sci. USA , vol.101 , pp. 14919-14924
    • Kuwahara, T.1
  • 133
    • 84940984328 scopus 로고    scopus 로고
    • In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria
    • Geva-Zatorsky, N. et al. In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat. Med. 21, 1091-1100 (2015).
    • (2015) Nat. Med. , vol.21 , pp. 1091-1100
    • Geva-Zatorsky, N.1
  • 134
    • 44449106055 scopus 로고    scopus 로고
    • A microbial symbiosis factor prevents intestinal inflammatory disease
    • Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008).
    • (2008) Nature , vol.453 , pp. 620-625
    • Mazmanian, S.K.1    Round, J.L.2    Kasper, D.L.3
  • 135
    • 22144490199 scopus 로고    scopus 로고
    • An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
    • Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
    • (2005) Cell , vol.122 , pp. 107-118
    • Mazmanian, S.K.1    Liu, C.H.2    Tzianabos, A.O.3    Kasper, D.L.4
  • 137
    • 84966293351 scopus 로고    scopus 로고
    • Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
    • Chu, H. et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352, 1116-1120 (2016).
    • (2016) Science , vol.352 , pp. 1116-1120
    • Chu, H.1
  • 138
    • 84957565779 scopus 로고    scopus 로고
    • Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
    • Dubin, K. et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun. 7, 10391 (2016).
    • (2016) Nat. Commun. , vol.7
    • Dubin, K.1
  • 139
    • 38049023064 scopus 로고    scopus 로고
    • Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis
    • Rabizadeh, S. et al. Enterotoxigenic Bacteroides fragilis: A potential instigator of colitis. Inflamm. Bowel Dis. 13, 1475-1483 (2007).
    • (2007) Inflamm. Bowel Dis. , vol.13 , pp. 1475-1483
    • Rabizadeh, S.1
  • 140
    • 33645096810 scopus 로고    scopus 로고
    • Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity
    • Kanauchi, O. et al. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J. Gastroenterol. 12, 1071-1077 (2006).
    • (2006) World J. Gastroenterol. , vol.12 , pp. 1071-1077
    • Kanauchi, O.1
  • 141
    • 0026731444 scopus 로고
    • Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States
    • Gordon, S. et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol. 30, 2373-2378 (1992).
    • (1992) J. Clin. Microbiol. , vol.30 , pp. 2373-2378
    • Gordon, S.1
  • 142
    • 84942982900 scopus 로고    scopus 로고
    • Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service
    • Lister, D. M. et al. Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service. Am. J. Infect. Control 43, 1061-1065 (2015).
    • (2015) Am. J. Infect. Control , vol.43 , pp. 1061-1065
    • Lister, D.M.1
  • 143
    • 84996950508 scopus 로고    scopus 로고
    • Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012)
    • Freitas, A. R. et al. Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012). J. Antimicrob. Chemother. 71, 3351-3366 (2016).
    • (2016) J. Antimicrob. Chemother. , vol.71 , pp. 3351-3366
    • Freitas, A.R.1
  • 144
    • 85006823088 scopus 로고    scopus 로고
    • A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies
    • Alatorre-Fernandez, P. et al. A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies. Am. J. Infect. Control 45, 260-266 (2017).
    • (2017) Am. J. Infect. Control , vol.45 , pp. 260-266
    • Alatorre-Fernandez, P.1
  • 145
    • 84924677754 scopus 로고    scopus 로고
    • Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis
    • Porter, L. A. & Goldberg, J. B. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis. Front. Cell. Infect. Microbiol. 1, 9 (2011).
    • (2011) Front. Cell. Infect. Microbiol. , vol.1 , pp. 9
    • Porter, L.A.1    Goldberg, J.B.2
  • 146
    • 85019259316 scopus 로고    scopus 로고
    • Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota
    • Pitt, J. M. et al. Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota. Oncoimmunology 6, e1132137 (2017).
    • (2017) Oncoimmunology , vol.6
    • Pitt, J.M.1
  • 147
    • 85034815842 scopus 로고    scopus 로고
    • Identification of unique neoantigen qualities in long-Term survivors of pancreatic cancer
    • Balachandran, V. P. et al. Identification of unique neoantigen qualities in long-Term survivors of pancreatic cancer. Nature 551, 512-516 (2017).
    • (2017) Nature , vol.551 , pp. 512-516
    • Balachandran, V.P.1
  • 148
    • 84884127512 scopus 로고    scopus 로고
    • Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
    • Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814-821 (2013).
    • (2013) Nat. Biotechnol. , vol.31 , pp. 814-821
    • Langille, M.G.1
  • 149
    • 84905730165 scopus 로고    scopus 로고
    • An integrated catalog of reference genes in the human gut microbiome
    • Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834-841 (2014).
    • (2014) Nat. Biotechnol. , vol.32 , pp. 834-841
    • Li, J.1
  • 150
    • 85030771846 scopus 로고    scopus 로고
    • Strains, functions and dynamics in the expanded Human Microbiome Project
    • Lloyd-Price, J. et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550, 61-66 (2017).
    • (2017) Nature , vol.550 , pp. 61-66
    • Lloyd-Price, J.1
  • 151
    • 85033585402 scopus 로고    scopus 로고
    • Towards standards for human fecal sample processing in metagenomic studies
    • Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069-1076 (2017).
    • (2017) Nat. Biotechnol. , vol.35 , pp. 1069-1076
    • Costea, P.I.1
  • 152
    • 85006049497 scopus 로고    scopus 로고
    • Current status and future perspectives of capsule endoscopy
    • Song, H. J. & Shim, K. N. Current status and future perspectives of capsule endoscopy. Intest. Res. 14, 21-29 (2016).
    • (2016) Intest. Res. , vol.14 , pp. 21-29
    • Song, H.J.1    Shim, K.N.2
  • 153
    • 85022334518 scopus 로고    scopus 로고
    • Fecal microbial transplantation in inflammatory bowel disease: A movement too big to be ignored
    • Laffin, M. & Madsen, K. L. Fecal microbial transplantation in inflammatory bowel disease: A movement too big to be ignored. Clin. Pharmacol. Ther. 102, 588-590 (2017).
    • (2017) Clin. Pharmacol. Ther. , vol.102 , pp. 588-590
    • Laffin, M.1    Madsen, K.L.2
  • 154
    • 84962788254 scopus 로고    scopus 로고
    • Microbiome and anticancer immunosurveillance
    • Zitvogel, L., Ayyoub, M., Routy, B. & Kroemer, G. Microbiome and anticancer immunosurveillance. Cell 165, 276-287 (2016).
    • (2016) Cell , vol.165 , pp. 276-287
    • Zitvogel, L.1    Ayyoub, M.2    Routy, B.3    Kroemer, G.4
  • 155
    • 85026895683 scopus 로고    scopus 로고
    • The evolution of the host microbiome as an ecosystem on a leash
    • Foster, K. R., Schluter, J., Coyte, K. Z. & Rakoff-Nahoum, S. The evolution of the host microbiome as an ecosystem on a leash. Nature 548, 43-51 (2017).
    • (2017) Nature , vol.548 , pp. 43-51
    • Foster, K.R.1    Schluter, J.2    Coyte, K.Z.3    Rakoff-Nahoum, S.4
  • 156
    • 84997610371 scopus 로고    scopus 로고
    • Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis
    • Ishikawa, D. et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm. Bowel Dis. 23, 116-125 (2017).
    • (2017) Inflamm. Bowel Dis. , vol.23 , pp. 116-125
    • Ishikawa, D.1
  • 158
    • 84977622019 scopus 로고    scopus 로고
    • Diet-microbiota interactions as moderators of human metabolism
    • Sonnenburg, J. L. & Backhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56-64 (2016).
    • (2016) Nature , vol.535 , pp. 56-64
    • Sonnenburg, J.L.1    Backhed, F.2
  • 159
    • 84969776957 scopus 로고    scopus 로고
    • Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota
    • Pflug, N. et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 5, e1150399 (2016).
    • (2016) Oncoimmunology , vol.5
    • Pflug, N.1
  • 160
    • 84977566637 scopus 로고    scopus 로고
    • The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia
    • Galloway-Pena, J. R. et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 122, 2186-2196 (2016).
    • (2016) Cancer , vol.122 , pp. 2186-2196
    • Galloway-Pena, J.R.1
  • 161
    • 84940055522 scopus 로고    scopus 로고
    • Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
    • Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973-1980 (2016).
    • (2016) Gut , vol.65 , pp. 1973-1980
    • Mima, K.1
  • 162
    • 85026371130 scopus 로고    scopus 로고
    • Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy
    • Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548-563 (2017).
    • (2017) Cell , vol.170 , pp. 548-563
    • Yu, T.1
  • 163
    • 85008223872 scopus 로고    scopus 로고
    • The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation
    • Routy, B. et al. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology 6, e1258506 (2017).
    • (2017) Oncoimmunology , vol.6
    • Routy, B.1
  • 164
    • 84937701770 scopus 로고    scopus 로고
    • Intestinal Blautia is associated with reduced death from graft-versus-host disease
    • Jenq, R. R. et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol. Blood Marrow Transplant. 21, 1373-1383 (2015).
    • (2015) Biol. Blood Marrow Transplant. , vol.21 , pp. 1373-1383
    • Jenq, R.R.1
  • 165
    • 85029481879 scopus 로고    scopus 로고
    • Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
    • Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156-1160 (2017).
    • (2017) Science , vol.357 , pp. 1156-1160
    • Geller, L.T.1
  • 166
    • 85034809112 scopus 로고    scopus 로고
    • Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
    • Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443-1448 (2017).
    • (2017) Science , vol.358 , pp. 1443-1448
    • Bullman, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.